When XRP launched in its early phase, many early buyers rode impressive growth as the market embraced its potential. T ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...

National Air and Space Museum research and curatorial associate director Jeremy Kinney provided introductory remarks before leading C-SPAN on a tour of the Smithsonian's facility in Washington, D.C.

American Tower Corporation (NYSE:AMT) stands as a prominent player in the communications infrastructure sector, operating an extensive portfolio of wireless and broadcast towers globally. The company ...

What if simple real-world actions, walking, checking in, and reviewing, could translate directly into token rewards rather ...

An RNA-based therapeutic approach led to transient activation of telomerase activity in a model of pulmonary fibrosis. A new report suggests that RNA-based human telomerase reverse transcriptase ...

The race to claim dominance among crypto presales in Q4 2025 is heating up, and two names are drawing particular attention: ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

Angelie: Good morning. My name is Angelie, and I will be your conference operator today. At this time, I would like to ...

This advisory highlights more than 100 poster abstracts that will be presented at ASH 2025 involving researchers ...

Revenue -- $1.2 million, representing a 32% increase, attributed primarily to higher procedure volumes for the Catamaran ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...